Telratolimod(MEDI9197) - Moligand™, ≥97% , Toll-like receptor 7 agonist, CAS No.1359993-59-1, Toll-like receptor 7 agonist

CAS: 1359993-59-1 Cat. No.: T414432 Summenformel: C36H59N5O2 Molekulargewicht: 593.89 PubChem CID: 56833311
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥97%
Synonyms
AKOS032946368 | N-(4-((4-Amino-2-butyl-1H-imidazo(4,5-C)quinolin-1-yl)oxy)butyl)octadecanamide | RRTPWQXEERTRRK-UHFFFAOYSA-N | N-(4-((4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)oxy)butyl)stearamide | SCHEMBL671176 | s9623 | TELRATOLIMOD [INN] | N-(4-{
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
Application
Drug Delivery, Surface Modification, PEGylation of Protein, Peptide & Oligo
★
Größe
Deutschland (EU)
USA*
Preis
Menge
5mg
T414432-5mg
—
3 Auf Lager
34,62€
10mg
T414432-10mg
—
1 Auf Lager
56,32€
25mg
T414432-25mg
—
2 Auf Lager
111,85€
50mg
T414432-50mg
—
2 Auf Lager
186,48€
Enter a quantity for the sizes you want to add.
🧪
Warum diese Qualität

Moligand™, ≥97% Moligand™ für empfindliche chromatographische und analytische Workflows, die minimale Basislinieninterferenzen erfordern.

🌡

Lagerung & Versand

Store at -20°C Versand Ice chest + Ice pads. Genaue Spezifikationen finden Sie im chargenspezifischen COA.

📋

Qualitätsdokumente

SDS, COA, Datenblatt und Spezifikationsblatt stehen zum Download bereit. Chargenspezifische COA über Chargennummernsuche abrufbar.

📚

Literaturbeleg

In 0 peer-reviewten Publikationen zu Chromatographie, organischer Synthese und Kreuzkupplungsreaktionen zitiert.

Übersicht

Information

Telratolimod Telratolimod (3M-052, MEDI9197) is an agonist of toll-like receptor 7 (TLR-7) and toll-like receptor 8 (TLR-8) with antitumor activity.


Targets

TLR7 ; TLR8


In vitro

3M-052 induces both TNFα and IFNα in human PBMCs in a manner indicative of a dual TLR7/TLR8 agonist. 3M-052 stimulates the production of IL8 in HEK293 cells stably expressing either human TLR7 or TLR8. In contrast, no IL8 is stimulated in empty vector control cells. The TLR8 agonist activity of 3M-052 may be of particular value in the immunization of neonates and infants whose monocytes and antigen presenting cells have a diminished capacity to generate TH1 polarizing signals to TNFα and IFNα.


In vivo

The co-administering CpG ODN with Telratolimod (3M-052) is remarkably effective at eliminating large established tumors and establishes long-term protective immunity. This anti-tumor activity is associated with a significant diminution in the frequency of tumor resident MDSC and accumulation of tumor-lytic NK and CD8 T cells, resulting in persistent anti-tumor immunity.


Cell Research(from reference)

Cell lines:PBMCs 

Concentrations:0.001 nM, 0.01 nM, 0.1 nM, 1 nM, 0.01 μM, 0.1 μM, 1 μM, 10 μM, 100 μM 

Incubation Time:16 h 

Spezifikationen

Synonyme
AKOS032946368 | N-(4-((4-Amino-2-butyl-1H-imidazo(4,5-C)quinolin-1-yl)oxy)butyl)octadecanamide | RRTPWQXEERTRRK-UHFFFAOYSA-N | N-(4-((4-amino-2-butyl-1H-imidazo[4,5-c]quinolin-1-yl)oxy)butyl)stearamide | SCHEMBL671176 | s9623 | TELRATOLIMOD [INN] | N-(4-{
Spezifikationen & Reinheit
Moligand™, ≥97%
Biochemische und physiologische Mechanismen
Telratolimod (3M-052, MEDI9197) is an agonist of toll-like receptor 7 (TLR-7) and toll-like receptor 8 (TLR-8) with antitumor activity.
Storage
Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
AGONIST
Mechanismus der Wirkung
Toll-like receptor 7 agonist
Reinheit
≥97%
Produkteigenschaften
ALogP
11.9
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/528767479
Kanonisches Lächeln
CCCCCCCCCCCCCCCCCC(=O)NCCCCON1C(=NC2=C1C3=CC=CC=C3N=C2N)CCCC
IUPAC Name
N-[4-(4-amino-2-butylimidazo[4,5-c]quinolin-1-yl)oxybutyl]octadecanamide
InChIKey
RRTPWQXEERTRRK-UHFFFAOYSA-N
INCHI
1S/C36H59N5O2/c1-3-5-7-8-9-10-11-12-13-14-15-16-17-18-19-27-33(42)38-28-22-23-29-43-41-32(26-6-4-2)40-34-35(41)30-24-20-21-25-31(30)39-36(34)37/h20-21,24-25H,3-19,22-23,26-29H2,1-2H3,(H2,37,39)(H,38,42)
Isomere SMILES
CCCCCCCCCCCCCCCCCC(=O)NCCCCON1C(=NC2=C1C3=CC=CC=C3N=C2N)CCCC
PubChem CID
56833311
Molekulargewicht
593.89

Dokumentation

📋 Sicherheitsdatenblatt (SDS)

Umfassendes Dokument zu Gefahren, Handhabung, Lagerung und Einhaltung regulatorischer Vorschriften.

<<<<<<< HEAD SDS herunterladen → ======= SDS herunterladen → >>>>>>> release248-p3

✅ Analysezertifikat (COA)

Chargenspezifische Qualitätsdaten. Geben Sie Ihre Chargennummer ein, um das genaue COA abzurufen.

COA nachschlagen →

📊 Datenblatt

Kurzübersicht über Produktspezifikationen und Anwendungen.

Datenblatt ansehen →

🔬 Spezifikationsblatt

Vollständige Qualitätsmerkmale und Akzeptanzkriterien für diese Qualität.

Spezifikationsblatt ansehen →

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlasseQuinolines and derivatives
SubclassImidazoquinolines
Intermediate Tree Nodes Not available
Direct ParentImidazoquinolines
Alternative Parents Aminoquinolines and derivatives  Imidazo-[4,5-c]pyridines  Aminopyridines and derivatives  N-substituted imidazoles  N-acyl amines  Imidolactams  Benzenoids  Heteroaromatic compounds  Secondary carboxylic acid amides  Amino acids and derivatives  Azacyclic compounds  Primary amines  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Imidazoquinoline - Aminoquinoline - Imidazo-[4,5-c]pyridine - Imidazopyridine - Aminopyridine - Fatty amide - Fatty acyl - Imidolactam - Benzenoid - Pyridine - N-acyl-amine - N-substituted imidazole - Azole - Heteroaromatic compound - Imidazole - Amino acid or derivatives - Carboxamide group - Secondary carboxylic acid amide - Azacycle - Carboxylic acid derivative - Organic nitrogen compound - Hydrocarbon derivative - Amine - Carbonyl group - Organic oxide - Organic oxygen compound - Primary amine - Organooxygen compound - Organonitrogen compound - Aromatic heteropolycyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as imidazoquinolines. These are aromatic heterocyclic compounds containing an imidazole ring fused to a quinoline ring system. In some configurations, the imidazole ring shares a nitrogen atom with the quinoline moiety.
External Descriptors Not available
3D-Struktur
Interaktives chemisches Strukturmodell





Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

10 results found

Lot NumberCertificate TypeDatumArtikel
A2416739A2416739Certificate of AnalysisOct 09, 2026 T414432
A2416740A2416740Certificate of AnalysisOct 09, 2026 T414432
A2416741A2416741Certificate of AnalysisOct 09, 2026 T414432
A2416742A2416742Certificate of AnalysisOct 09, 2026 T414432
I2628602I2628602Certificate of AnalysisSep 04, 2026 T414432
I2628603I2628603Certificate of AnalysisSep 04, 2026 T414432
I2628604I2628604Certificate of AnalysisSep 04, 2026 T414432
I2628605I2628605Certificate of AnalysisSep 04, 2026 T414432
A2416738A2416738Certificate of AnalysisDec 12, 2023 T414432
A2416760A2416760Certificate of AnalysisDec 12, 2023 T414432
Chemische und physikalische Eigenschaften
LöslichkeitDMSO: 60 mg/mL (101.02 mM), Need ultrasonic
Molekulargewicht593.900 g/mol
XLogP311.900
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count5
Rotatable Bond Count25
Exact Mass593.467 Da
Monoisotopic Mass593.467 Da
Topological Polar Surface Area95.100 Ų
Heavy Atom Count43
Formal Charge0
Complexity709.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.